Sparton Medical Systems Recognized for Teaming with BioMarker Strategies and HS Design to Automate Live Tumor-Cell Processing
STRONGSVILLE, Ohio--(BUSINESS WIRE)--Sparton Corporation (NYSE:SPA) announces that Sparton Medical’s collaborative design and engineering work with HS Design in Gladstone, NJ has helped BioMarker Strategies become a finalist for a 2012 Medical Design Excellence Award (MDEA).